GHK-Cu / Copper Peptide
Locks collagen early; supports pigment evenness.
SC injection; IV infusion; topical cream — 200–300 mcg IV in core formulas; 100–200 mcg SC injection 1–2x/week; 1.0–2.0 mg topical solution to wound; injectable 2 mg weekly for joint/skin protocols
What It Is
GHK-Cu is a tripeptide (Glycyl-L-histidyl-L-lysine) complexed with copper. It is a fibroblast signaler that promotes collagen remodeling, angiogenesis, and orderly healing of skin.
Mechanism
GHK-Cu boosts collagen and elastin production, improves skin texture and wound contraction, and has anti-inflammatory action. It signals fibroblasts to lay down parallel, elastic collagen rather than disordered scar tissue, and has anti-inflammatory effects to ensure "lattice order." It also exhibits anti-tumorigenic effects in some studies and reduces cancer cell adhesion. In the RECODEX context it "locks collagen" in an ideal, orderly pattern.
How Dr. Emer Uses It
Dr. Emer incorporates GHK-Cu throughout the RE:SKN and STABILIS protocols. It is given as 200–300 mcg IV in core IV drips (CORE GENESIS, PRIME, STABILIS) as a collagen-organizing peptide. Topically applied as a cream once wound surface is closed for skin resurfacing patients, and as 100–200 mcg SC injection around injuries 1–2x/week. In the Wolverine Stack it is an optional adjunct. Used for a 65-year-old post-menopausal patient with osteoarthritis as injectable 2 mg weekly to reduce inflammation and improve skin/hair quality of life.
Key Benefits
- ✓Signals fibroblasts to produce parallel, elastic collagen (not disordered scar)
- ✓Boosts collagen and elastin production for improved skin texture
- ✓Promotes wound contraction and orderly healing
- ✓Anti-inflammatory action that ensures "lattice order" during repair
- ✓Supports pigment evenness and collagen remodeling post-laser
- ✓Anti-tumorigenic effects in some studies; supports cancer adjunctive care
Pairs Well With
Used In Programs
Safety & Considerations
Available as a cosmeceutical; topically very safe (just slight blue tint from copper sometimes). Injected, it is still well-tolerated; monitor copper levels if someone is on long-term high-dose GHK. Large doses can transiently lower copper levels — monitor if long-term. No acute toxicity. Experimental/investigational for injectable use; ensure no copper overload with short-term use.
Begin Your RECODEX™ Protocol
All peptide therapies are prescribed under direct medical supervision.
Book a Consultation
